Skip to main content
Clinical Trials/ISRCTN52227045
ISRCTN52227045
Active, not recruiting
未知

A comprehensive life-style and multi-omics integrative approach to study metabolic processes related to cognitive function, cognitive decline and progression to dementia

Institut d'Investigació Sanitària Pere Virgili0 sites300 target enrollmentMay 16, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Institut d'Investigació Sanitària Pere Virgili
Enrollment
300
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 16, 2023
End Date
December 31, 2033
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Institut d'Investigació Sanitària Pere Virgili

Eligibility Criteria

Inclusion Criteria

  • 1\. Men and women aged between 45\-80 years old
  • 2\. Mini\-Mental State Examination (MMSE) \= 26, hospital anxiety scale \= , hospital depression scale \= 11

Exclusion Criteria

  • 1\. Mini\-Mental State Examination (MMSE) \<26 or inability to give informed consent
  • 2\. Diagnosis of dementia
  • 3\. Presence of depressive symptoms (Geriatric Depression Scale \=5\)
  • 4\. Major medical or psychiatric condition
  • 5\. Evidence of impairment due to psychoactive drugs
  • 6\. Alcohol or drug abuse
  • 7\. Inability to perform imaging studies (i.e.CAT, MR)
  • 8\. Other conditions under the neurologist criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials